Where does Immusoft's cap table come from?

Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Immusoft's 6 recorded funding rounds.

Premier Alternatives

Immusoft

Seattle, WA · Founded 2009 · Privately Held (backing)

Developer of novel therapies designed for the treatment of rare diseases. Immusoft is based in Seattle, WA and was founded in 2009. It was valued at $65.2 million at its later-stage round in Mar 2025, the last priced event on record. It has raised $54.8 million across 6 recorded rounds; the latest was a $4.6 million seed round in May 2024.

PMV mark · valuation

$65.2M

Oct 2026

Priced at

its later-stage round

Mar 2025

Total raised

$54.8M

Last round

Seed Round

May 2024

Cap table — not yet on record

Immusoft's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.

Free account

More of Immusoft with a free account

·The complete investor list: 29 names
·Watch Immusoft: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Frequently asked about Immusoft

Where does Immusoft's cap table come from?: Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Immusoft's 6 recorded funding rounds.